Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia
Blood Adv
.
2019 Nov 26;3(22):3709-3712.
doi: 10.1182/bloodadvances.2019000775.
Authors
Hyun Don Yun
1
,
Sunita Nathan
1
,
Melissa Larson
1
,
Mohammad J Hussain
1
,
Deborah A Katz
1
,
Ankur Varma
1
,
Ira Miller
2
,
Celalettin Ustun
1
Affiliations
1
Division of Hematology, Oncology and Cell Therapy, Department of Medicine, and.
2
Section of Hematopathology, Department of Pathology, Rush University, Chicago, IL.
PMID:
31765477
PMCID:
PMC6880901
DOI:
10.1182/bloodadvances.2019000775
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Aniline Compounds
Granulocyte Precursor Cells*
Humans
Leukemia, Myeloid, Acute*
Pyrazines
Substances
Aniline Compounds
Pyrazines
gilteritinib
Grants and funding
T32 HL007062/HL/NHLBI NIH HHS/United States